The University of Oxford and the Ludwig Institute for Cancer Research are adding to our growing group of cancer researchers. We are seeking individuals at mid-stage career stage with interest in joining world leading Institutions as an Associate Member/ Professor.
The University of Oxford is a world-class research environment which has made a substantial commitment to biomedical research. The Ludwig Institute is part of the Nuffield Department of Medicine situated within the Old Road Campus in Headington Oxford and forms the focus of cancer research throughout the University. We closely collaborate with other departments and institutes on the campus including the Department of Oncology, Kennedy Institute (immunology), the Jenner Institute (vaccines), the Big Data Institute (computational biology), IDRM (developmental biology), STRUBI (structural biology) and the Target Discovery Institute amongst many others. We also have ready access to investigators working throughout the University in areas such as chemistry, mathematics, physics and biology.
The Ludwig Institute is an international organisation that supports 3 core-funded branches (Oxford, Princeton and Lausanne) as well as individual investigators throughout the world. Its aim is to advance our basic knowledge of cancer and apply this towards improvement in cancer care. The Oxford branch has particular expertise in epigenetics and the development of novel technologies to study this problem. We are especially interested in growing our expertise in epitranscriptomics, RNA biology, single-cell/spatial approaches, microenvironment, and structural epigenetics, but are open to any area of novel investigation. We encourage cross-disciplinary science which brings together different approaches, including close collaboration between basic scientists and clinical colleagues in the nearby cancer hospital.
Our research is well-supported through a core funding mechanism, which provides support for PI salary, PhD students, postdoctoral fellows and consumables. We have access to state-of-the-art core facilities including high resolution microscopy, cryoEM, ultra-sensitive mass spectrometry and CRISPR screening.
Candidates should hold a relevant PhD level qualification and have led impactful and novel independent research programs in a cancer related field. They will have a strong international reputation, and this will be evidenced by high impact publications, external grants, collaborations and scientific accomplishments. We offer competitive funding, strong institutional commitment, comprehensive benefits, and an outstanding work and life environment with family friendly policies, an on- campus nursery and easy access to London and European cities.
Via the APPLY button - Interested parties should complete our expression of interest form and prepare and upload the following materials:
*
o Cover letter
o CV
o Research plan
o Names and emails of 3 referees
The closing date is midnight Friday 13th February 2026.